ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,633.32
      1.28%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      06/26/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces First Patient Dosed in a Phase 2 Clinical Trial of ATI-501 Oral Suspension in Patients with Al...NASDAQ:ACRSAclaris Therapeutics Inc
      06/15/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics Expands Leadership Team, Appointing Dr. David Gordon as Chief Medical OfficerNASDAQ:ACRSAclaris Therapeutics Inc
      06/12/20186:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/12/20187:00AMGlobeNewswire Inc.Phase 3 data in the online Journal of the American Academy of Dermatology show Aclaris' ESKATA™ is safe and effective in tr...NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20184:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20184:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20184:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20184:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20184:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      06/08/20187:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      06/07/20183:43PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      06/04/20184:05PMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/30/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering ESKATANASDAQ:ACRSAclaris Therapeutics Inc
      05/24/20184:05PMGlobeNewswire Inc.Landec Corporation to Nominate Two New Board DirectorsNASDAQ:ACRSAclaris Therapeutics Inc
      05/21/20184:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/17/20187:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/17/20189:30AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRSAclaris Therapeutics Inc
      05/16/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Poster Presentations at International Investigative Dermatology 2018 MeetingNASDAQ:ACRSAclaris Therapeutics Inc
      05/15/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics to Support Symposium on JAK Inhibitors at the International Investigative Dermatology 2018 MeetingNASDAQ:ACRSAclaris Therapeutics Inc
      05/11/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics to Present at the 2018 American Hair Research SummitNASDAQ:ACRSAclaris Therapeutics Inc
      05/10/20185:00PMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      05/09/20184:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/09/20184:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/09/20184:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/09/20184:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/09/20184:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/09/20184:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      05/08/20185:26PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      05/08/20184:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      05/08/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics Reports First Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments...NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS

      Your Recent History

      BIT
      UB30FE
      UniCredit Bank
      BIT
      S31844
      Societe Generale Effekten
      Delayed Upgrade Clock